Latest filing published 19 Nov 2019 for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, €3,392.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert A. Mello: trading record in brief
Robert A. Mello discloses dealings in 2 companies, chiefly Iris International Inc and Arrhythmia Research Technology Inc /DE/. We count 82 filings; the first trade dates from 2 June 2005 and the latest from 18 November 2019.
The open-market side counts 2 purchases for €25k alongside 16 sales for €1.5M. Netting one side against the other leaves €1.5M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 35 share grants and 25 option exercises.
The latest filing, published on 19 November 2019, reports a share grant of €3,392 in Arrhythmia Research Technology Inc /DE/. The latest purchase dates back some time: it was published 2,873 days ago, on 27 December 2018. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert A. Mello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,589 shares@ US$2.364.9% of flowCommon StockSEC:0000819689-19-000104:0
- 1,630 shares@ US$2.307.0% of flowCommon StockSEC:0000819689-19-000078:0
- 1,471 shares@ US$2.557.0% of flowCommon StockSEC:0000819689-19-000052:0
- 1,500 shares@ US$2.506.5% of flowCommon StockSEC:0000819689-19-000005:0
- 309 shares@ US$3.101.6% of flowCommon StockSEC:0000819689-18-000072:1
- 8,843 shares@ US$3.0947.0% of flowCommon StockSEC:0000819689-18-000072:0
- 1,183 shares@ US$3.175.2% of flowCommon StockSEC:0000819689-18-000068:0
- 1,084 shares@ US$3.464.7% of flowCommon StockSEC:0000819689-18-000050:0
- 989 shares@ US$3.793.9% of flowCommon StockSEC:0000819689-18-000038:0
- 1,068 shares@ US$3.513.7% of flowCommon StockSEC:0000819689-18-000008:0
- 2,038 shares@ US$3.687.9% of flowCommon StockSEC:0000819689-17-000055:0
- 1,884 shares@ US$3.987.9% of flowCommon StockSEC:0000819689-17-000047:0
- 1,974 shares@ US$3.807.9% of flowCommon StockSEC:0000819689-17-000047:1
- 2,616 shares@ US$4.3013.1% of flowCommon StockSEC:0000819689-17-000004:0
- 68,809 shares@ US$19.50Common StockSEC:0001181431-12-056183:0
- 100 shares@ US$19.50Common StockSEC:0001181431-12-056183:1
- 53,283 shares@ US$19.50Common StockSEC:0001181431-12-056183:7
- 25,695 shares@ US$19.50Common StockSEC:0001181431-12-056183:8
- 209 sharesCommon StockSEC:0001209191-12-047755:0
- 281 sharesCommon StockSEC:0001209191-12-047755:1
- 269 shares@ US$19.52Common StockSEC:0001209191-12-047755:2
- 208 sharesCommon StockSEC:0001209191-12-036610:0
- 281 sharesCommon StockSEC:0001209191-12-036610:1
- 268 shares@ US$11.30Common StockSEC:0001209191-12-036610:2
- 209 sharesCommon StockSEC:0001209191-12-021577:0
25 of 72 declarations